Racial differences in long-term renal allograft outcome.
Georgi
B
B
Department of Surgery, State University of New York Health Science Center at Brooklyn, USA.
Sumrani
N
N
Maursky
V
V
Hassoun
A
A
Hong
J H
JH
Yu
L
L
JeanBaptiste
F
F
Distant
D A
DA
Mocerino
M
M
Sommer
B G
BG
D000328:Adult; D000349:Africa / Q000208:ethnology; D000368:Aged; D001208:Asia / Q000208:ethnology; D044383:Black People; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005006:Ethnicity; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control; D006085:Graft Survival; D006630:Hispanic or Latino; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D044469:Racial Groups; D015996:Survival Rate; D013997:Time Factors; D014019:Tissue Donors; D014184:Transplantation, Homologous; D014481:United States; D044465:White People; D001741:Black or African American
D007166:Immunosuppressive Agents; D016572:Cyclosporine